{"id":5981,"date":"2023-10-27T14:20:35","date_gmt":"2023-10-27T14:20:35","guid":{"rendered":"https:\/\/communitypharmacy.com\/?p=5981"},"modified":"2023-10-27T14:20:35","modified_gmt":"2023-10-27T14:20:35","slug":"what-you-need-to-know-about-the-new-covid-19-vaccines","status":"publish","type":"post","link":"https:\/\/communitypharmacy.com\/2023\/10\/what-you-need-to-know-about-the-new-covid-19-vaccines\/","title":{"rendered":"What You Need to Know About the New COVID-19 Vaccines"},"content":{"rendered":"

While COVID-19 might not be as pressing of a problem as it was during the peak of the pandemic, the virus and its many variants still pose significant health risks that require updated vaccine protection to combat. <\/span>
\n<\/span>
\n<\/span>As they have in years past, another <\/span>surge<\/span><\/a> of cases has been anticipated by experts as we enter the holiday season. Along with well-known variants like Omicron, 2023 has seen other COVID mutations like <\/span>XBB.1.5. rise, which previous year\u2019s vaccines were not designed to protect against.<\/span><\/p>\n

New Vaccines Now Available<\/b>
\n<\/span><\/p>\n

Fortunately, Pfizer and Moderna\u2019s <\/span>newest vaccines<\/span><\/a> (Comirnaty and Spikevax respectively) have an improved formula for 2023 which were approved for <\/span>commercialization<\/span><\/a> and use in September. <\/span>
\n<\/span>
\n<\/span>Both operate under the similar principle of previous mRNA vaccines by introducing a small, similar piece of the virus (and its common variants) into the body. This simulates an actual exposure to the virus, which helps the body\u2019s immune system become better prepared and effective if it encounters the actual virus later. <\/span>
\n<\/span>
\n<\/span>However, there are some notable updates with the new vaccines you should be aware of. Before we dive into the key details, but if you should have any further questions regarding vaccine options, you can always <\/span>contact<\/span><\/a> your nearest Community Pharmacy, and our staff will be happy to answer.<\/span><\/p>\n


\nKey Information Regarding Comirnaty & Spikevax<\/b><\/p>\n

Developed by Pfizer and BioNTech, Corminaty has an exemplary <\/span>95%<\/span><\/a> efficacy rate against the COVID-19 infection. Similarly, Spikevax vaccine offers high levels of protection against the virus after thousands of rounds of <\/span>clinical testing<\/span><\/a>.<\/span>
\n<\/span>
\n<\/span>While neither will stop a recipient from outright contracting the virus, what they can do is stem the severity of the virus\u2019 effect upon the body. Those who have received the vaccine are far less likely to have serious effects that require hospitalization when compared to the unvaccinated. This helps the individual handle the immediate effects of the disease and prevents hospitals from becoming overcrowded with patients when cases rise.<\/span>
\n<\/span>
\n<\/span>Further notable details regarding both of the newly approved vaccines include:<\/span>
\n<\/span><\/p>\n